• Article: Types of myocardial injury and mid-term outcomes in patients with COVID-19
• Article: Risk prediction in patients with COVID-19 based on haemodynamic assessment of left and right ventricular function
• Articel: Digital transformation of major scientific meetings induced by the COVID-19 pandemic: insights from the ESC 2020 annual congress
• Article: Disparities in patient engagement with video telemedicine among high-video-use providers during the COVID-19 pandemic
• Article: Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation four months after infection
• Article: The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey
• Insights: Cardiothoracic intensive care in the time of COVID-19

• C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?
• What we (don’t) know about myocardial injury after COVID-19
• Perspective - Long term effects of COVID-19 with T. Luescher and B. Parapid

• COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with CVD
• How COVID-19 lockdown impacts outcomes of patients with new onset AFib
• Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
• SARS-CoV2: Use of inhibitors of the renin-angiotensin system in patients with COVID-19

Access the full podcast library on all CV topics

From the European Heart Journal

• PE in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome
• Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19
• COVID-19 and emissions: an opportunity for sustainable global health
• Influenza vaccination: a ‘shot’ at INVESTing in cardiovascular health
• Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity
• All-cause mortality and location of death in patients with CVD before, during, and after the COVID-19 lockdown
• Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by CMR
• Re-purposed antiviral drugs without a purpose in COVID-19: a valuable lesson for clinicians
• Xenotransplantation in the era of a zoonotic pandemic
• Characteristics and outcomes of in- and out-of-hospital cardiac arrest during COVID-19 pandemic
• C-reactive protein and clinical outcomes in patients with COVID-19
• Ventricular arrhythmia burden during the COVID-19 pandemic
• Hypertension and RAS blockers are not associated with expression of ACE2 in the kidney 
• ACE2 levels in relation to risk factors for COVID-19 in two large cohorts of patients with Afib 
• Pathological features of COVID-19-associated MI: a multicentre cardiovascular pathology study
• Management of patients needing urgent electrophysiology and/or electrostimulation procedures 
• COVID-19 is, in the end, an endothelial disease 
• Pulmonary embolism in COVID-19 patients: a French multicentre cohort study
• How COVID-19 lockdown impacts outcomes of patients with new onset atrial fibrillation
• COVID-19 kills at home: relationship between epidemic and increase of out-of-hospital cardiac arrests
• COVID-19: from epidemiology to treatment 
• Association of hypertension and antihypertensive treatment with COVID-19 mortality   
• Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 
• Characteristics and clinical significance of cardiac injury in patients with severe COVID-19
• Circulating plasma concentrations of ACE2 in patients with HF and effects of RAA inhibitors
• Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Italy
• A tale of two countries. How to build resilient healthcare systems
• Deleterious effects of viral pneumonia on cardiovascular system
• From ‘Do No Harm’ to ‘Do Maximal Good’: an evolving concept   
  
• SARS-CoV-2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? 
• Coronaviruses and the cardiovascular system: acute and long-term implications 
  
  

From Cardiovascular Research 

• Erratum to: Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of Evidence
• COVID-19 related cardiac complications – from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart
• Cardiovascular RNA markers and AI may improve COVID-19 outcomes: position paper from the EU-CardioRNA COST Action CA17129
• Double trouble: combined CV effects of particulate matter exposure and COVID-19
• Non-classical CD14^dim CD16⁺ monocytes: outcome predictors in CAD+SARS-CoV-2 patients
• Regional and global contributions of air pollution to risk of death from COVID-19
• Higher mortality of COVID-19 in males: Sex differences in immune response and CV comorbidities
• SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
• The CSO cardiovascular and pulmonary imaging in COVID-19 (CISCO-19) study
• Vascular risk factors, Framingham risk score, and COVID-19: community-based cohort study
• Single-cell analysis of receptor ACE2 and spike protein priming expression of proteases in the heart
• Hospital admissions with ACS during the pandemic in German cardiac care unit
• Risk factors for myocardial injury and death in patients with COVID-19: a cohort study with chest CT 
• COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis and treatment 
• Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications  
• Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections  
• The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and CVD  
• The ACE2 expression indicates new potential mechanism of heart injury in patients with SARS-CoV-2  
  
  

From European Heart Journal - Quality of Care & Clinical Outcomes

• Types of myocardial injury and mid-term outcomes in patients with COVID-19
• Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews
• Substantial decline in hospital admissions for HF accompanied by increased community mortality during COVID-19 pandemic
• The association between CVD admission rates, the COVID-19 lockdown and reopening of a nation: a Danish nationwide cohort study
• Admission rates and care pathways in patients with afib during the COVID-19 pandemic – Insights from Germany
• Impact of COVID-19 pandemic on acute CVD patient care and management
• Cardiovascular comorbidities as predictors for severe COVID-19 infection or death
• Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality
• Cumulative hospitalization deficit for cardiovascular disorders in Germany during COVID-19
• Patient response, treatments and mortality for AMI during COVID-19

From European Heart Journal - Cardiovascular Pharmacotherapy

• Incidence of cerebral venous thrombosis and covid-19 vaccination
• RAS blockers, risk of SARS-CoV-2 infection and outcomes from COVID-19: systematic review and meta-analysis
• Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalised patients
• Management of pregnancy-related hypertensive disorders in patients infected with SARS-CoV-2
• A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on ACEis or ARBs  
• Association between renin–angiotensin system inhibitors and COVID-19 complications
• Mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme: treatment options

From European Heart Journal - Digital Health

• Disparities in patient engagement with video telemedicine among high-video-use providers during the COVID-19 pandemic
• Digital transformation of major scientific meetings induced by the COVID-19 pandemic: insights from the ESC 2020 annual congress
• Disparities in patient engagement with video telemedicine among high video use providers during the COVID-19 pandemic
• Voice-based screening for SARS-CoV-2 exposure in cardiovascular clinics
• Smartwatch detected high-degree atrioventricular block requiring pacemaker implantation after TAVR during COVID-19
• Remote monitoring of patients with heart failure during the first national lockdown for COVID-19 in France
• Social determinants of telemedicine utilization in ambulatory cardiovascular patients during the COVID-19 pandemic
• AAD loading at home using remote monitoring during COVID-19
• How to adapt a hypertension prevention campaign during COVID-19: a Korean example
• Use of smartphone-operated ECG for home ECG surveillance in COVID-19 patients
• CIEDs replacement in patients followed by remote monitoring during COVID-19 lockdown

From European Heart Journal - Cardiovascular Imaging

• Risk prediction in patients with COVID-19 based on haemodynamic assessment of left and right ventricular function
• Myocardial perfusion scintigraphy during the COVID-19 pandemic - findings from the university teaching hospital in Slovenia
• Wells and Geneva decision rules to predict pulmonary embolism: can we use them in Covid-19 patients?
• Implementation of Rapid CMR Protocol in the COVID-19 era: improving scanning efficiency and increasing scanning capacity
• Impact of the COVID-19 pandemic in the MR availability for iron overloaded patients
• Prognostic value of pre-hospitalization stress perfusion CMR to predict death in patients hospitalized for COVID-19
• Rapid cardiovascular magnetic resonance protocol utilizing compressed sensing real-time imaging during the COVID-19 pandemic
• Prevalence of cardiac magnetic resonance myocarditis after SARS-CoV-2 infection
• Automated myocardial segmentation in native t1-mapping cardiovascular magnetic resonance images based on machine learning: a validation study in the UK biobank"s covid-19 subset
• Cardiac magnetic resonance in COVID-19 positive and probable cases: A report from a high volume CMR centre in Ireland
• LV longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection
• Prognostic value of right ventricular dilatation in patients with COVID-19: a multicentre study
• Quantitative pixel-wise analysis of native T1 mapping for identification of cardiac involvement in severe acute respiratory syndrome coronavirus 2 infection
• Early cardiac involvement in patients with acute COVID-19 infection identified by multiparametric CV MRI
• Segmental and GLS differences between children with MIS temporally associated with COVID-19 and Kawasaki disease
• Prognostic utility of quantitative offline 2D-echocardiography in hospitalised patients with COVID-19
• The evaluation of myocardial performance index in patients with COVID-19: follow-up study
• LV longitudinal strain alterations in asymptomatic or mildly symptomatic children with recent SARS-CoV-2 infection
• Clinical outcome analysis in patients with COVID-19 using echocardiography and biochemical markers
• Evolution of cardiac function in COVID-19 patients in the ICU: insights from machine learning
• Performing a cardio-thoracic MRI in COVID-19: comprehensive assessment of heart, pulmonary arteries and lungs
• Multisystem inflammatory syndrome in an adult with SARS-CoV-2 infection  
• Multimodality cardiac evaluation in children and young adults with multisystem inflammation
• Multisystem manifestations of COVID-19 in a patient presenting to a heart attack centre
• Global evaluation of echocardiography in patients with COVID-19
• CMR and serology to diagnose COVID-19 infection with primary cardiac involvement
• Myocardial work index: a glimmer of hope in COVID-19  
• Myocarditis detected after COVID-19 recovery  
• Unusual presentation of acute coronary syndrome in a patient with SARS-CoV-2 infection 
• A case of Takotsubo cardiomyopathy with COVID-19
• The role of cardiovascular imaging for myocardial injury in hospitalised COVID-19 patients 
• Myocarditis revealing COVID-19 infection in a young patient  
• Acute pulmonary embolism with intramural RV thrombus in SARS-CoV-2-positive patient 
• EACVI recommendations on precautions, indications, prioritisation, and protection

From EP Europace

• The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey
• Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study
• Atrial fibrillation burden during the coronavirus disease 2019 pandemic
• Repolarization abnormalities at admission predict 30-day outcome in COVID-19
• The TeleCheck-AF project on remote app-based management of Afib during the COVID-19 pandemic: Patient experiences
• Inappropriate sinus tachycardia in post-COVID-19 syndrome
• Cardiac arrhythmias in COVID-19: mechanisms, outcomes and the potential role of proarrhythmia
• Oral anticoagulant therapy at hospital admission associates with lower mortality in older COVID-19 patients with Afib. An insight from the COVID Registry
• ECG wearable rhythm monitoring in COVID-19 patients
• Telemedicine-based early rule out and follow-up ECG algorithm for COVID-19 patients
• Electrocardiogram-based mortality prediction in patients with COVID-19 using machine learning
• Observations during the COVID-19 pandemic in CHF patients with complex devices in a tertiary care cardiac centre using the HeartLogic software
• Assessing Afib ablation priority during COVID-19 - does use of patient questionnaires help in stratification above physician assessment?
• Home fitting of ECG ambulatory monitors during COVID-19
• What can we find in the ECG recording in convalescent from COVID-19 with mild and moderate course
• Afib and COVID-19 in older patients: a complex, dangerous, association. An analysis of the GeroCovid Registry
• Impact of COVID-19 lockdown in patients with implantable cardioverter and CRT-D: insights from daily remote monitoring transmissions
• Electrocardiographic characteristics of patients with COVID-19 related pneumonia at first presentation
• Monitoring of QTc interval in patients with COVID-19. First experience with a portable EKG-recording device
• Modelling sudden cardiac deathrisks factors in patients with COVID-19: the HCQ and azithromycin case
• The European TeleCheck-AF project on remote app-based management of Afib during the COVID-19 pandemic: centre and patient experiences
• Cardiac operations and interventions during the COVID-19 pandemic: a nationwide perspective
• Reduction in new cardiac electronic device implantations in Catalonia during COVID-19
• Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19
• High-degree atrioventricular block in COVID-19 hospitalized patients
• Electrocardiographic findings at presentation and clinical outcome in patients with COVID-19
• Electrophysiology in the time of coronavirus: coping with the great wave
• Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings
• Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: insights
• Practice update for telehealth and arrhythmia monitoring during and after a pandemic  
• COVID-19 and QT interval prolongation: more than just drug toxicity?  

From European Journal of Heart Failure 

• Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation four months after infection
• HFpEF according to the HFA‐PEFF score in COVID‐19 patients: clinical correlates and echocardiographic findings
• December 2020 at a glance: focus on COVID‐19, comorbidities and palliative care
• Characterization of NT‐PROBNP in a large cohort of COVID‐19 patients
• Circulating cardiovascular microRNAs in critically ill COVID‐19 patients
• Association between RAASi use and COVID-19 hospitalisation and death: 1,4 million patient registry
• Hemodynamic characteristics of COVID‐19 patients with ARDS requiring MV
• HF impact on the clinical course and outcomes of COVID-19 patients: an Italian study
• In‐hospital care in AHF during the COVID‐19 pandemic: a German example
• Heart Failure in COVID-19 patients: prevalence, incidence and prognostic implication  
• Temporal trends in decompensated HF and outcomes during COVID‐19: A London multisite report
• Pathogenesis and management of myocardial injury in coronavirus disease 2019
• Viral presence guided immunomodulation in lymphocytic myocarditis: an update
• Detection of viral SARS‐CoV‐2 genomes and histopathological changes in endomyocardial biopsies
• ACE‐inhibitors and angiotensin‐2 receptor blockers not associated with severe SARS‐CoV-2 infection   
• Impact of COVID‐19 on HF hospitalisation and management: report from a HF unit in London   
• Management of HF patients with COVID‐19: a joint position paper of the Chinese HF Association & National HF Committee and HFA
• COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation 
• Consequences of COVID-19 pandemic for self‐care in-patients with a left VAD 
• Caring for people with HF beyond COVID-19: advantages of home telemonitoring
• Myocardial localisation of coronavirus in COVID‐19 cardiogenic shock

From European Heart Journal - Acute Cardiovascular Care

• Impact of COVID 19 pandemic on ACS hospitalisations, and related invasive procedures
• The impact of lockdown during COVID-19 on the timing of presentation and early outcomes of patients with STEMI
• Acute myocarditis in COVID-19 patients. Clinical features, severity and outcomes. Results from Car-COVID19
• Coronary angioplasty and COVID-19: are heparin requirements and thrombotic complications increasing?
• Increased occurrence of Takotsubo syndrome during COVID-19 lockdown
• Prehospital management of STEMI during COVID-19 lockdown. A single centre experience
• The effect of the COVID-19 pandemic on time to angiography and outcomes in patients presenting with non-STEMI
• COVID-19 era: time for temporary mechanical circulatory support?
• An outbreak of infective endocarditis during the COVID-19 pandemic? An observational retrospective single centre study
• Acute coronary syndrome in COVID-19 times: could it be business as usual?
• Primary PCI: a reasonable treatment for STEMI care during the COVID-19 pandemic
• Impact of the COVID-19 pandemic on admission for acute heart disease in a level II coronary unit
• The impact of nationwide lockdown on ACS hospitalization rate in the Western Macedonia regional hospital of Greece
• Cardiovascular biomarkers in patients with COVID-19
• Cardiac complications in patients hospitalised with COVID-19
• Levels of hs-troponin I predict mortality in COVID-19 patients with cardiac injury
• Cardiac injury is associated with severe outcome and death in patients with COVID-19 infection
• Implications for prehospital, emergency and hospital care in patients with ACS  
• Respiratory management in severe acute respiratory syndrome coronavirus 2 infection  
• Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol  
• Medical treatment options for COVID-19
• The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions
• Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds 
• Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic 

From European Journal of Preventive Cardiology  

• Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis
• Under-prescription of direct oral anticoagulants for treatment of non-valvular atrial fibrillation and VTE in the COVID-19 lockdown period
• Delivering a dietetic intervention to cardiovascular patients in the COVID era
• Digital home-based multidisciplinary cardiac rehab: the way to counteract physical inactivity during the COVID-19 pandemic?
• Cardiac rehabilitation and secondary prevention in COVID-19 times: Single center experience
• Effects of COVID-19 lockdown on physical activity in coronary patients on a phase III cardiac rehabilitation program
• COVID-19 era in long-term cardiac rehabilitation programs: how did physical activity and sedentary time change compared to previous years?
• Home blood pressure during COVID-19 related lockdown in patients with hypertension
• COVID-19 pandemic stresses trigger ST-elevation and non-ST-elevation AMI in Middle Eastern individuals not infected with the virus
• Exercise-based cardiac rehabilitation adaptation protocol during COVID-19 pandemic achieved similar results as compared to non-pandemic usual practice: a single-center retrospective study
• An indian clinician outlook on hypertension care during COVID-19 pandemic
• Home-based cardiac rehabilitation during COVID-19 pandemic: effectiveness of an educational intervention
• Physical activity and sedentary behaviour in cardiovascular disease patients during the COVID-19 lockdown in the Netherlands; a longitudinal cohort study
• Outcomes of STEMI hospitalizations during COVID-19 era
• Design of an E-Health platform using artificial intelligence technologies for the surveillance and prevention of patients with cardiovascular diseases against COVID-19
• Impact of lockdown in patients with congestive heart failure during the COVID-19 pandemic
• Blood pressure level and laboratory indicators of disease severity in patients with arterial hypertension and COVID-19
• Impact of an online cardiac rehabilitation program after an acute coronary syndrome during SARS-CoV-2 pandemic
• HFrEF patient activity levels during COVID-19 lockdown: A comparison between physical activity questionnaires and implantable devices data
• ECG markers of malignant arrhythmias risk in patients with arterial hypertension hospitalized for COVID-19 pneumonia
• COVID-19 era in long-term cardiac rehabilitation programs: how was muscle strenght and lean mass affected in cardiovascular patients?
• Body composition, lipid profile and mediterranean diet adherence in cardiovascular disease patients attending a long-term exercise-based cardiac rehabilitation program during COVID-19 pandemic
• Pulmonary embolism during the COVID-19 pandemic
• Web discussions on cardiovascular diseases: assessing the impact of COVID-19 pandemic. An Italian prospective analysis
• Smoking and associated unhealthy lifestyle behaviours in patients with chronic cardiac diseases during COVID-19 related lockdown
• Effectiveness of rehabilitation in post-COVID compared with post-cardiosurgery patients. A single center experience
• COVID-19 era in long-term cardiac rehabilitation programs: how did physical activity and sedentary time change compared to previous years?
• Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic
• Anticoagulation therapy in NVAF in the COVID-19 era: is it time to reconsider our therapeutic strategy?
• QTc-interval prolongation and increased risk of sudden cardiac death associated with HCQ
• Delphi consensus recommendations on how to provide CV rehab in the COVID-19 era
• Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia
• Exercise in the severe SARS-CoV-2 era: Question and answer session with EAPC experts
• Effect of coronavirus infection on the human heart: A scoping review    
• Cardiac patient care during a pandemic: how to reorganise a HF unit at the time of COVID-19   
• Cardiovascular disease and COVID-19: les liaisons dangereuses
• Amiodarone as a possible therapy for coronavirus infection

From European Journal of Cardiovascular Nursing

• Should I stay or should I go? An exploration of the decision-making behaviour of acute cardiac patients during the COVID-19 pandemic
• The lived experience of patients with a left ventricular assist device during the COVID-19 pandemic: a qualitative study
• The impact of COVID-19 on recovery after heart surgery: preliminary findings from the CardiacCovid Study
• Transitioning a cardiovascular health and rehabilitation programme to a virtual platform during COVID-19
• Living with heart failure during the COVID-19 pandemic: an interpretative phenomenological analysis
• Human connection: a valuable element for health-related quality of life outcomes in cardiac rehabilitation during COVID-19
• A framework for risk stratification of burnout due to Covid-19 in nurses using personas" creation
• Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with COVID-19: a multicenter cohort study
• Co-design of cardiac rehabilitation delivery in the aftermath of COVID-19, putting the patient view back in the picture
• The frailty and falling in related with functional performance, balance and physical activity in elderly during COVID-19 pandemics
• App based monitoring of heart rate via FibriCheck to facilitate teleconsultations: from COVID-19 to clinical practice? 
• An online functional assessment experience in individuals over 65+ during COVID-19 pandemics: physiotherapist opinion & participant opinion
• How the COVID-19 pandemic affected utilisation of cardiac rehabilitation in rural Australia?
• Throwing cardiac rehabilitation into the 21st Century: a focus group study exploring the impact of COVID-19 on cardiac rehabilitation delivery in Victoria, Australia
• Triple drug therapy to manage uncontrolled BP in hypertensive patients during COVID-19 lockdown: perspectives from India
• Facilitating transcatheter aortic valve implantation in COVID-19    
• Delivering healthcare at distance during the pandemic: experiences from clinical practice
• Delivering healthcare remotely to cardiovascular patients during COVID-19: a review of evidence

From ESC Heart Failure 

• Admission NT-proBNP and outcomes in patients without history of heart failure hospitalized with COVID-19
• The prognostic value of serial troponin measurements in patients admitted for COVID-19
• Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection
• Late phase of COVID-19 pandemic in general cardiology. A position paper of the ESC Council for Cardiology Practice
• Successful heart transplantation for COVID‐19‐associated post‐infectious fulminant myocarditis
• Cardiac performance in patients hospitalized with COVID‐19: a 6 month follow‐up study
• Outcomes of COVID-19 among veterans with pre‐existing diagnosis of HF
• Impact of telemedicine on the management of HF patients during COVID-19 pandemic
• Beyond the stethoscope: managing ambulatory heart failure during the COVID‐19 pandemic
• COVID‐19 impact on the management of HF: a UK patient questionnaire study
• HFpEF in COVID-19 patients: the promising role of diuretic therapy in critically ill patients
• COVID‐19‐convalescence phase unmasks a silent MI due to coronary plaque rupture
• Myocarditis and coronary aneurysms in a child with acute respiratory syndrome coronavirus 2
• Elevated α‐HBDH as an independent prognostic factor for mortality in hospitalised COVID-19 patients
• MI in severe COVID‐19 is similar to pneumonias of other origin: results from a multicentre study
• Increased mortality and worse cardiac outcome of acute MI during the early COVID‐19 pandemic
• Recurrent autoimmune myocarditis in a young woman during the COVID-19 pandemic
• Ventricular assist device for a COVID-2019‐affected heart
• Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in COVID-19 patients
• Increased susceptibility to SARS‐CoV‐2 infection in patients with reduced LVEF
• Implication of inhaled nitric oxide for the treatment of critically ill COVID‐19 patients with PH
• Sudden cardiogenic shock mimicking fulminant myocarditis in a surviving COVID-19 teenager
• Delayed acute myocarditis and COVID‐19‐related multisystem inflammatory syndrome
• Reduction in heart failure hospitalisation rate during coronavirus disease 19 pandemic outbreak
• Echocardiographic abnormalities and predictors of mortality: the ECHOVID‐19 study
• Fulminant myocarditis in a patient with COVID-19 and rapid myocardial recovery after treatment
• Bedside chest ultrasound to distinguish HF from pneumonia‐related dyspnoea in older patients
• The effect of concomitant COVID‐19 infection on outcomes in patients hospitalised with HF
• Risk factors for myocardial injury in patients with coronavirus disease 2019 in China
• Impact of lockdown on patients with CHF during the pandemic
• Swollen heart in COVID‐19 patients who progress to critical illness: a perspective from echo‐cardiologists
• Fatal lymphocytic cardiac damage in COVID‐19: autopsy reveals a ferroptosis signature
• Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during COVID-19
• Management of catheter ablation in arrhythmia patients during COVID-19
• Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment
• The overlooked chamber in coronavirus disease 2019
• In‐hospital mortality in heart failure in Germany during the COVID‐19 pandemic
• Takotsubo syndrome as a complication in a critically ill COVID‐19 patient
• Relating ACE inhibitors or ARBs with incidence or mortality from COVID‐19
• Quarantine effect on accelerometer‐assessed physical activity of HF patients

From EuroIntervention 

• In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients   
• Coronary thrombosis in a patient with COVID-19 and haemophagocytic lymphohistiocytosis   
• In-hospital outcomes of patients with ST-segment elevation myocardial infarction and COVID-19
• Extensive coronary artery thrombosis complicating COVID-19 infection and HLH

From other ESC sources

• Webinars - Position statements - Commentaries

• Cardiothoracic intensive care in the time of COVID-19
• COVID-19 Pandemic : Georgia Nurses Association Response (State of Georgia, USA)
• Challenges and lessons from COVID-19: perspectives of a female interventional cardiologist from a developing country
• My COVID-19 story in one of the major heart and chest hospital in Sudan
• The integrated Community Chest Pain Clinic: moving chest pain assessment from the hospital to the community; a timely response to the COVID-19 pandemic in Ireland
• Impact of COVID-19 on quality of life for cardiac rehabilitation patients
• A personal experience of a nurse attending to severely ill COVID-19 patients
• Getting lost in the fog of the pandemic: insights from the ‘second wave’ of COVID-19
• Brazilian nursing and the COVID-19 pandemic challenges - Brazil
• What COVID-19 is taking away from us – Milan, Italy
• WATCH - Cardiac involvement in COVID-19 - Staffordshire, UK
• COVID-19: the aftermath - Piacenza, Italy 
• Psychological support for staff – London, UK
• m-Health: Apps to the rescue – Maastricht, Netherlands  
• Connecting COVID-19 patients with their families – Madrid, Spain 
• Young cardiologist in the eye of the storm – Madrid, Spain
  
• COVID-19 patients: scared and alone - Pavia, Italy
• Protecting cardiologists during the COVID-19 epidemic – Wuhan, China 
• And the wave became a tsunami – Paris, France 
• Diagnosing the first COVID-19 patient in Italy – Codogno, Italy 
  
• Exhausted and trying to cope – Lombardy, Italy
• COVID-19: digital health swings into action

 General resources 

• Clinical, psychological, educational, and professional impact of the COVID-19 pandemic in young Spanish cardiologists
• Socioeconomic status and cardiovascular health in the COVID-19 pandemic
• WHO coronavirus disease (COVID-19) dashboard
• Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility 
• Epidemiology and transmission of COVID-19 in 391 cases and 1,286 of their close contacts in China 
• New NIH resource to analyse COVID-19 literature: the COVID-19 portfolio tool  
• OUP resources on COVID-19
• WHO information on COVID-19

Overview of management of coronavirus

• 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
• Experts question guidance to reuse PPE 
• Handbook of COVID-19: Prevention and treatment

Medication

• Treatments and vaccines approved by the EMA for COVID-19
  
• Reminder of risk of serious side effects with chloroquine and hydroxychloroquine 
• ESC resources on chloroquine and cardiovascular side effects
• Thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up

COVID-19 and CVD

• Practical recommendations for the management of diabetes in patients with COVID-19
• Renin–Angiotensin–Aldosterone system blockers and the risk of COVID-19
• Renin–Angiotensin–Aldosterone system inhibitors and risk of COVID-19
• Cardiovascular disease, drug therapy, and mortality in COVID-19
• Pulmonary and cardiac pathology in COVID-19: first autopsy series from New Orleans
• COVID-19: providing ongoing care to patients with cardiovascular disease in a pandemic
• COVID-19 and the cardiovascular system
• Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?